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Abstract: Preventing the development of osteomyelitis while enhancing bone regeneration is
challenging, with relatively little progress to date in translating promising technologies to the clinic.
Nanoscale hydroxyapatite (nHA) has been employed as a bone graft substitute, and recent work has
shown that it may bemodifiedwith silver to introduce antimicrobial activity against known pathogens.
The aim of this study was to incorporate silver-doped nHA into electrospun scaffolds for applications
in bone repair. Silver-doped nHA was produced using a modified, rapid mixing, wet precipitation
method at 2, 5, 10 mol.% silver. The silver-doped nHA was added at 20 wt.% to a polycaprolactone
solution for electrospinning. Bacteria studiesdemonstrated reducedbacterial presence,withEscherichia
coli and Staphylococcus aureus undetectable after 96 h of exposure. Mesenchymal stem cells (MSCs)
were used to study both toxicity and osteogenicity of the scaffolds using PrestoBlue® and alkaline
phosphatase (ALP) assays. Innovative silver nHA scaffolds significantly reduced E. coli and S. aureus
bacterial populations while maintaining cytocompatibility with mammalian cells and enhancing
the differentiation of MSCs into osteoblasts. It was concluded that silver-doped nHA containing
scaffolds have the potential to act as an antimicrobial device while supporting bone tissue healing for
applications in orthopedic and dental bone surgery.
Keywords: electrospinning; antimicrobial; nano-hydroxyapatite; silver; toxicity; bone regeneration
1. Introduction
Preventing deep bone infections after surgery and enhancing bone regeneration reduces the time
required for patient recovery and the costs associated with long hospital stays. Deep bone infections
are very challenging to treat once established due to the difficulty of achieving a suitable antibiotic
concentration in the affected area and ensuring all bacteria have been removed. Bacteria such as
Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) are responsible for causing bone infections
post-surgery [1,2], and the application of excessive antibiotics can lead to antimicrobial resistance.
Antibacterial poly(methyl methacrylate) beads have been used routinely for treating infections in
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a reactive manner with additional disadvantages of requiring surgical removal after the treatment
ends [3]. Silver has often been used to successfully treat bacterial and fungal infections [4,5] and can be
delivered in a localized area. Metallic implants coated with silver have been investigated to prevent
infections [6]. However, silver by itself does not enhance wound healing and can have a toxic effect on
mammalian cells at higher concentrations [7,8].
To facilitate bone healing, surgeons currently employ hydroxyapatite in granular or paste form to
stimulate bone regrowth. Hydroxyapatite is the mineral component of bone and can be manufactured
synthetically and has been demonstrated to aid in bone regeneration [9]. Nanoscale hydroxyapatite
(nHA) is an increasingly popular biomaterial due to its similarity to the hydroxyapatite in human bone
and tooth enamel. Our group recently produced a bioinspired nHA material through a rapid mix
preparation, which is slightly calciumdeficient to bettermimic biological apatite [10]. Using nHA-based
medical devices to increase the regeneration rate of the bone after surgery could greatly decrease
patient healing times. Unfortunately, despite its success in aiding bone regeneration, hydroxyapatite
has no innate antimicrobial properties to prevent infection. Moreover, the implantation of medical
devices provides an increased risk of bacterial colonization and eventual biofilm formation if left
untreated [11]. Once a biofilm has been established it is very difficult to treat using antibiotics and
even surgical intervention involves a high risk of reoccurrence [12].
There is growing interest in using a combination of silver and hydroxyapatite to produce amaterial
with both antimicrobial/antifungal [13,14] and bone-regenerating properties [15–18]. Jiang et al. [19]
produced foamed polyurethane scaffolds containing up to 40 wt.% silver phosphate particles (Ag3PO4)
and nHA. These mold-formed scaffolds were porous and eluted silver for up to 22 days without
toxic effects on the human osteosarcoma cell line MG63. Saravanan et al. [20] produced scaffolds
using the freeze-drying technique incorporating nano-hydroxyapatite with nanoparticles of silver.
Wilcock et al. [21] developed a novel, rapid mixing, wet precipitation method of producing bioinspired,
nanoscale hydroxyapatite crystals doped with silver for antimicrobial action. A degradable scaffold
could be placed against existing implants or used to hold packed bone substitutes (e.g., bone chips)
into a bone defect.
The biomaterials’ research community has been keenly interested in using electrospinning as a
containment system for ceramic-derived materials including hydroxyapatite [22]. Electrospinning
is a technique for producing fibrous scaffolds that roughly resemble the body’s extracellular matrix.
These can be made porous to allow cell thoroughfare or nanoscale to act as a barrier to cells, fulfilling a
wide variety of applications. Ciraldo et al. [23] investigated three different manufacturing approaches
using mesoporous glasses containing silver. These were glass coatings prepared using electrospraying,
sol-gel methods, and directly spinning with polycaprolactone (PCL). For electrospinning, the authors
were limited to 5% mesoporous glasses in PCL but did not investigate antimicrobial action. However,
a recent paper by the same group demonstrated that the mesoporous glasses loaded with silver were
antimicrobial [24]. Anjaneyulu et al. [25] manufactured doped hydroxyapatite through the sol-gel
method and electrospunwith poly(vinyl alcohol). Schneider et al. [26] electrospun tricalciumphosphate
nanoparticles into poly(lactic-co-glycolic acid) (PLGA) scaffolds, looking at a single concentration of
silver, but did not investigate mammalian toxicity of the scaffold. Furtos et al. [27] electrospun a PCL
scaffold to contain both nHA and amoxicillin, which they tested against four bacterial strains and
found that increasing the nHA content reduced the loading efficiency of the antibiotic.
A variety of polymers and calcium compounds have been used for producing these antimicrobial
scaffolds. Different manufacturing technologies have also been employed to produce these as scaffolds.
A relatively small number of the above publications have reported testing their material with primary
mesenchymal stem cells (MSCs), which are key to understanding bone-healing mechanisms. Few of
the published reports have investigated microbiological testing beyond agar diffusion assays with no
time course elution antimicrobial testing.
Here we present the fabrication of novel, dual-function scaffolds that combine silver to impart
antimicrobial properties and hydroxyapatite to enhance bone regeneration. Our laboratory previously
J. Funct. Biomater. 2020, 11, 58 3 of 17
developed a silver-doped nano-hydroxyapatite material formed by the wet precipitation method [21].
Here we show the incorporation of this innovative material into an electrospun scaffold alongside a
thorough investigation of metal ion release, antimicrobial activity against clinically relevant bacterial
strains, and in vitro biocompatibility using cultured mammalian MSCs. This research has provided
an important proof-of-concept study that has the potential to underpin the development of a new
generation of dual-action medical devices to address the growing challenges of deep bone infection
and antimicrobial resistance.
2. Materials and Methods
2.1. Silver Nano-Hydroxyapatite (Ca10(PO4)6(OH)2) Manufacture via Wet Precipitation
This was based on our previously published methods [10,21]. In brief, calcium hydroxide (Sigma
Aldrich, Dorset, UK) (50 mmol) was suspended in 500 mL deionized water (dH2O) into which 0, 1,
2.5, or 5 mmol silver nitrate (Sigma Aldrich, UK) (corresponding to 0, 2, 5, or 10 mol%, respectively)
was added and stirred at 400 rpm for 1 h on a hotplate (Fisher Scientific, Loughborough, UK) at
90 ◦C. Phosphoric acid (Sigma Aldrich, UK) (30 mmol) was dissolved in 250 mL dH2O, poured into
the calcium and silver preparation, and stirred for a further hour. The suspension was left to settle
overnight, after which the supernatant was poured off and the silver-doped nHA suspension was
washed with dH2O (3 × 500 mL). The silver-doped nHA suspensions were dried at 60 ◦C and ground
in an agate mortar and pestle.
2.2. Imaging the Silver Nano-Hydroxyapatite and Electrospun Fibers Using SEM
Dried nHA powder or a 5 × 5 mm section of electrospun scaffold was attached to a carbon tab and
sputter gold coated and then imaged using a TESCAN VEGA3 SEM (Tescan, Brno, Czech Republic)
with an accelerating voltage of 15 kV.
2.3. Imaging the Silver Nano-Hydroxyapatite Using Transmission Electron Microscopy (TEM) and
Energy-Dispersive X-Ray Spectroscopy (EDX)
The nHA powder (0.1 g) was dispersed in ethanol in an ultrasonic bath (ThermoFisher, Shanghai,
China) for 1 h and a drop was placed onto a copper mounting grid with carbon film and allowed to dry
under ambient conditions. Samples were then imaged on a transmission electron microscope (Tecnai
G2 F30, ThermoFisher, Shanghai, China) under standard imaging and EDX detecting elements Ca, P,
Ag, and O. EDX settings used were 20 kV, takeoff 14.8, amp time 7 µs, and 126.5 eV resolution.
2.4. Analyzing Crystal Phases Present Using X-Ray Diffraction (XRD)
Phase analysis was performed on powdered samples using XRD (STOE IP, Darmstadt, Germany)
with Cu Kα λ = 1.5418 Å radiation to determine the crystal structure of thematerials. The diffractometer
was operated at 40 kV and 35 mA, with a 2θ range of 20–50◦. The following The International Centre
for Diffraction Data Powder Diffraction (ICDD-PDF) cards were used for phase identification: 9-432
hydroxyapatite, 6-505 silver phosphate.
2.5. Electrospinning Polycaprolactone (PCL) and Incorporating the Ag–nHA
Polycaprolactone (average 80,000 Mn, Sigma, UK) was dissolved in a specific solvent and then
propelled by an electric field onto a collector where polymer fibers formed as the solvent evaporated.
Adding both the silver-doped and undoped nHA powder to the solution at 20 wt.% allowed it to be
incorporated into the electrospun scaffold. PCL (1.5 g) was dissolved into a solvent mixture (90%
Dichloromethane [DCM], 10% Dimethylformamide [DMF]) (Sigma Aldrich, UK) and stirred using a
magnetic stirrer bar (5 mm bar, Sigma Aldrich, UK) for 2 h. The nHA powders were incorporated at
20wt.%of the PCL component and added into the dissolvedPCL solution. Thepolymer-ceramic-solvent
mixtures were placed in an ultrasonic bath for 30 min, before stirring using a magnetic stirrer bar for
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30 min to ensure even distribution of powder in the solution. A 1-mL Luer-Lok syringe (BD, EU) was
loaded with 1 mL of the PCL/nHA solution and this was electrospun using a custom electrospinning
rig described previously [28]. In total, 2 mL of solution at 1 mL/hr was used to fabricate each scaffold
at 17 kV with a spinning gap between the needle and collector of 20 cm.
2.6. Accelerated Degradation Study of Electrospun Scaffolds and Release Profile
To investigate the rate at which nHA was released during scaffold degradation, an accelerated
degradation study was performed over 30 days. Samples were weighed and added to a 5-mL solution
of 0.1 M NaOH (Sigma Aldrich, UK) in dH2O and placed in an oven at 37 ◦C. At each time point (days
0, 1, 7, 14, 21, and 28) material was also weighed and 0.5 mL of solution was removed, which was
replaced with fresh solution. The solutions obtained were diluted to 5 mL using dH2O.
2.7. Inductively Coupled Plasma (ICP) Measurement of Material and Degradation Product
To ascertain the presence and abundance of various elements within the sample, ICP was utilized.
Solid samples (e.g., 0.25 g–0.5 g) were weighed into a glass tube and 9 mL of concentrated hydrochloric
acid (Sigma Aldrich, UK) added and 3 mL of concentrated nitric acid (Sigma Aldrich, UK) added.
The samples were then placed into the heating block and the temperature was gradually raised to 150 ◦C
and maintained at this temperature for 30 min. After removal from the block and cooling, the samples
were diluted to 50 mL with 1% nitric acid. Samples were diluted down to 1 in 100 for analysis. Samples
were analyzed using an ICP-OES (Spectro-Ciros-Vision Optical Emission Spectrometer (Spectro, Kleve,
Germany) using a procedure with a detection limit of at least 10 ppm.
2.8. Scaffold Preparation for Cell Culture
Disks of each electrospun scaffold were prepared and sterilized prior to culture with cells. Using
a 13 mm cork borer, disks (13 mm) of each scaffold were punched out of the primary collector sheet.
On the day of use, the culture scaffolds were disinfected with 70% ethanol (Sigma Aldrich, UK) in
dH2O for 30 min and then washed three times in dH2O for 5 min.
2.9. Contact Bacterial Toxicity Test
Antimicrobial activity was investigated using a classical diffusion agar assay. Isolates of E. coli
and S. aureuswere purchased from the China Center of Industrial Culture Collection (CICC, Beijing,
China): E. coli, CICC23657 and S. aureus, CICC10384. The bacterial suspensions at stationary phase
were firstly obtained by culture in LB (Luria-Bertani) medium overnight at 37 ◦C in a 120-rpm shaker.
Then 1 mL of the E. coli and S. aureus suspensions were pipetted from the overnight phase into another
100-mL flask containing 50 mL of fresh LB. The mixture was then cultured at 37 ◦C for another 6 h
to obtain bacterial suspensions at exponential growth phase. After that, the bacterial suspension
was centrifuged at 8000 rpm, washed, and resuspended in sterilized physiological saline to reach a
concentration of 1 × 107 colony forming units (CFU)/mL. Then, 0.1 mL of the bacteria suspension with
1 × 107 CFU/mL was pipetted and plated on the agar plate uniformly. Three disks of the electrospun
material (12 mm diameter) were placed on each Petri dish. These were incubated at 37 ◦C for 24 h.
The zone of inhibition ring around the electrospun scaffolds was measured.
2.10. Antimicrobial Diffusion Toxicity Test
A disk of the electrospun scaffold (12 mm diameter) was immersed into the bacteria suspension
(10 mL) containing 1 mL 107 CFU/mL and 9 mL sterile physiological saline in a 15-mL falcon tube.
The falcon tubes were placed on a carousel (IKA, Staufen, Germany) and rotated 360◦ in the z axis
at 30 rpm in an incubator at 37 ◦C. At the time points 3, 18, 24, 48, 72, and 96 h, 200 µL of phosphate
buffered saline (PBS) was removed and serially diluted to 10−7 before 100 µL of diluted solutions were
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added to an agar plate and incubated for 24 h before imaging. The CFUs on plates were counted using
the dilution, which was the highest with all bacterial colonies visible as single entities.
2.11. Rat Mesenchymal Stem Cell (MSC) Isolation and Passage
MSCs were isolated from four 4–5-week-old male Wistar rat femurs following the method
previously described in literature [29,30]. Briefly, the femur was removed from the rats, opened at
both ends, and flushed with media. This was then cultured to collect adherent cells, cells from all
rats were intermixed, and cells were passaged twice before use. Cells were cultured in minimum
essential medium (αMEM) supplemented with 10 U/mL penicillin (Sigma Aldrich, UK), 0.1mg/mL
streptomycin (Sigma Aldrich, UK), 20mM alanyl-glutamine (Sigma Aldrich, UK), and 10% v/v
fetal bovine serum (FBS; Biosera, Heathfield, UK). Cells were passaged 1:5 using trypsin-EDTA
(ethylenediaminetetraacetic acid, Sigma Aldrich) and used below passage 10 for toxicity studies and
below passage 5 for differentiation studies.
2.12. Noncontact Mammalian Cell Toxicity Study
Toxicity of elution from the electrospun scaffolds was measured by suspending the material over
on cultured cells for 24 h. Both primary rat MSCs and the established fibroblast 3T3 cell line were used
to test this material. Both cell lines were treated the same in the experiment apart from the rat MSCs
were cultured in αMEM as described above and the 3T3 cells were cultured in high-glucose Dulbecco’s
Modified Eagle Medium (DMEM) with 10% FBS, both supplemented with 20 mM alanyl-glutamine
(Sigma Aldrich, UK) and 0.1 mg/mL of streptomycin (Sigma Aldrich, UK). Cells were trypsinized
and added to a 24-well plate (ThermoFisher, Loughborough, UK) at 30,000 cells per well in 1 mL of
respective media. The cells were cultured for 24 h in an incubator at 37 ◦C and 5% CO2. Media was
replaced and a Transwell® insert (Millicell Hanging Cell Culture Insert, polyethylene terephthalate
(PET) 0.4 µm, 24-well) was added to each well containing cells. In triplicate, the following were added
to the Transwell® inserts: No scaffold (positive), 1 mL 70% industrial methylated spirit (IMS) (negative),
0% Ag nHA scaffold, 5% Ag nHA scaffold, and 10% Ag nHA scaffold. One mL of media was added to
each Transwell® insert and plates were incubated for 48 h at 37 ◦C and 5% CO2. After 48 h the cells
within the wells were imaged and metabolic activity was assessed using PrestoBlue™ (ThermoFisher,
UK). Media was removed and 700 µL of PrestoBlue™ (10% in complete media) was added to each well
and the well plate was incubated for two hours. From the wells, 200 µL of PrestoBlue™ was added in
triplicate to a 96-well plate. The fluorescence of the solutions was measured using a plate reader (FLx
800 Bio-Tek Instruments; Thermo Fisher Scientific, UK) with an excitation wavelength of 535 nm and
an emission wavelength of 590 nm. The experiment was repeated four times (N = 4, n = 3).
2.13. Contact Biocompatibility Study on Rat MSCs
A direct-contact biocompatibility study was used to assess the toxicity of the scaffolds on cells
over 21 days. Rat MSCs were used for this study. Disks of each scaffold were added in triplicate to a
24-well plate and 1 mL of media was added to each for 30 min (including a tissue culture plastic [TCP]
control). Cells were trypsinized, suspended in media, and then 30,000 cells were added to each well.
Well plates were agitated to aid even cell-seeding across the scaffold. Well plates were incubated for
24 h before cell metabolic activity was measured using PrestoBlue™. The scaffolds were transferred to
a new well plate before PrestoBlue™ to avoid interference of cells growing on the tissue culture plastic
surrounding the scaffold. PrestoBlue™was measured at 4, 7, 14, and 21 days in culture. N = 2, n = 3.
2.14. Live and Dead Cell Staining
Cells were stained with two dyes to identify if the cell was alive or if the cell scaffold was disrupted
(dead). Cells were stained using the LIVE/DEAD™ Viability/Cytotoxicity Kit (Thermofisher, UK) as
per the instructions. In brief, cells were washed in PBS and then Calcien and Ethidium homodimer-1
(both at 5 µM concentration) were incubated with cells in media for 30 min. Samples were imaged
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using a fluorescent microscope (Axioplan 2, Zeiss, Jena, Germany) using the built-in filters for FITC
(calcein) and TRITC (Ethidium homodimer-1).
2.15. Total Sample DNA and Alkaline Phosphatase Production Measurements
Alkaline phosphatase (ALP) is an early indicator of MSC differentiation to osteoblasts and can
be measured using an ALP detection test. ALP was normalized to DNA to give a reading of alkaline
phosphatase activity per cell regardless of cell number. Media was removed and samples washed
three times with PBS. Cell digestion buffer was made up using deionized water and 1% triton X-100
(Sigma, UK). Samples were incubated at 4 ◦C for 1 h in the cell digestion buffer. The samples were then
subjected to two freeze–thaw cycles (–20 ◦C to room temperature), which included solution agitation
by pipetting when thawed to ensure thorough lysis of cells. After the second freeze–thaw cycle, an
alkaline phosphatase diethanolamine detection kit was used to assess the alkaline phosphatase activity
of the cultures. Then, 40 µL of cell culture lysate solution was placed in a 96-well plate in triplicate
with 210 µL alkaline phosphatase reaction buffer. A standard curve of para-nitrophenyl (pNP) product
was prepared with concentrations of 250, 100, 50, 10, and 0 nmole.ml−1 pNP in the alkaline phosphate
reaction buffer. Then, 250 µL of the standard solutions were added in triplicate to the 96-well plate.
The para-nitrophenylphosphate (pNPP) substrate solution was prepared by dissolving 6.6 mg pNPP
per 1 mL of dH2O. Then, 10 µL substrate was then added to each well using a multichannel pipette
and the plate was incubated in the dark at 37 ◦C. The plate was monitored for color change and, at an
appropriate time point, the absorbance at 405 nm was read, ensuring that the readings were within the
range provided by the standard solutions. The amount of pNP in the sample wells was then calculated
using the standard curve and used as a measure of ALP activity.
After a further freeze–thaw cycle, Quant-iT™ PicoGreen® dsDNA assay (ThermoFisher, UK) was
used in accordance with the manufacturer’s instructions to quantify the DNA content of the cultures.
In detail, 50 µL of cell culture lysate was placed in a 96-well plate in triplicate along with 50 µL dH2O.
A standard curve of DNA was also prepared in triplicate with final concentrations of 1000, 500, 100, 50,
10, 5, and 0 ng.mL−1 when 100 µL of PicoGreen reagent was added to the 100 µL of standard solution
in each well. Then, 100 µL of freshly made PicoGreen reagent was added to all the wells using a
multichannel pipette. The plate was incubated in the dark for 4 min, after which the fluorescence was
read using an excitation wavelength of 485 nm and an emission wavelength of 528 nm. The standard
curve was plotted and used to convert the fluorescence units of the wells into the DNA content of the
original cultures.
2.16. Statistical Methodology
Statistical analysis was conducted using ANOVA run with multiple comparisons using GraphPad
Prism 8 (GraphPad Software, Inc., San Diego, CA, USA) with significance indicated with * when
p < 0.05. No demarcation of lower p values was used as all were tested with p = 0.05.
3. Results
3.1. Analysis of Prepared Nanoscale Hydroxyapatite
Nano-hydroxyapatite was prepared via the rapid mixing technique previously published [10].
Using TEM, the nanoscale hydroxyapatite particles were visualized and contained crystalline and
amorphous regions, typically less than 100 nm in size. Silver was found within the nanoscale
hydroxyapatite particles, with the visible formation of nanoparticles of silver. Both materials showed
the peaks associated with hydroxyapatite in XRD patterns. XRD showed the presence of silver
phosphate peaks but only for the 10 mol.% silver-containing material (Figure 1a). Despite this, in both
materials silver nanoparticles were visible under TEM; EDX confirmed that the darker regions found
under the TEM contained silver. See Supplementary Figure S1 for EDX mapping of all elements found
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in sample Figure 1e. The size distribution of particles’ diameter between nHA and nHA with 10 mol.%
silver substituted in was found to be similar, with an average of 37 and 40 nm, respectively (Figure 1f).

ﾛ ﾜ
Figure 1. Evaluation of silver-containing nanoscale hydroxyapatite (a) XRD patterns of 5 and
10 mol.% silver doped nanoscale hydroxyapatite (Ag nHA), identifying peaks for hydroxyapatite
Ca10(PO4)6(OH)2 and silver phosphate (Ag3PO4) phases within the sample. Silver phosphate was only
identified in the 10 mol.% silver-containing material. Plot line 1 (blue) is 10 mol.% Ag nHA and plot line
2 (green) is 5 mol.% Ag nHA; (b) TEM image of nHA sample containing 5 mol.% silver. Silver deposits
visible and highlighted by black arrows; (c) TEM at higher magnification on one of the silver deposit
areas; (d) TEM image of nHA sample containing 10 mol.% silver. Larger silver deposit noted by black
arrow; (e) Spatial EDX map of location of silver, mapped over the same location as that boxed in (d);
(f) Particle diameter comparison between nHA and nHA with 10 mol.% silver shown as a Tukey box
plot, ns = not significant; (g) TEM micrograph of nHA nanoscale particles.
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3.2. Ensuring Encapsulation of nHA by Electrospun Fibers
Both silver and nondoped nHA were electrospun into polycaprolactone (PCL) scaffolds with a
thickness of between 150 and 200 µm. SEM images showed incorporation of large particles in the
fibers that were not observed in plain PCL scaffolds (Figure 2a). When digested, ICP analysis showed
that plain PCL had very low levels of elements found within Ag-nHA (Figure 2b). The electrospun
nHA showed the presence of calcium and phosphorus but not silver. Both electrospun scaffolds with
silver-containing nHA showed the presence of silver alongside calcium and phosphorus (Figure 2b).
This demonstrated that nHA was successfully incorporated into the electrospun fibers.

Figure 2. Scaffold fibers containing nHA (a) SEM micrographs of electrospun scaffold.
Top: Polycaprolactone (PCL) scaffold. Middle: PCL scaffold containing nHA. Bottom: PCL scaffold
containing 10 mol.% Ag nHA. Different magnifications were used to visualize encapsulation of nHA
particles into the electrospun scaffold; (b) Inductively coupled plasma (ICP) analysis of dissolved
electrospun scaffolds showing mg/kg of elements present. All % Ag materials are in mol.%.
3.3. Investigation of Silver Release and Scaffold Loss in Accelerated Degradation Study
An accelerated degradation assay was performed using sodium hydroxide at 37 ◦C to understand
thedegradationprofile of the electrospun scaffolds and toobserve releaseprofiles (Figure 3). All scaffolds
degraded at the same rate with the presence of nHA having no apparent effect on degradation profile
(Figure 3a). Cumulative release of silver was observed for the full 30 days (Figure 3b). The plot
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of release rate (Figure 3c) indicated that in the early period of days 1 to 5 the release was from
surface-bound origins, whereas from days 7 onwards the release was from silver within the polymer
that was then released through degradation. Mass loss from degradation was nonexistent in the 1- to
7-day period and then rapidly degraded from there, which reinforced the conclusions drawn from the
silver release rate.

Figure 3. Accelerated degradation study of electrospun scaffolds containing nHA, over a 28-day period
in 0.1 M sodium hydroxide. (a) Remaining weight over degradation time of different mol.% silver
scaffolds; (b) Release profile of silver from an electrospun scaffold containing 10 mol.% Ag nHA over a
28-day period; (c) Plot of the silver release rate per day. All % Ag materials are in mol.%.
3.4. Antimicrobial Impact of Scaffolds
Both silver-containing scaffolds showed an antibacterial effect on both agar diffusion and on
bacterial suspensions. PCL-only scaffolds and thosewith undoped nHA showedno innate antimicrobial
action. Scaffolds containing silver of any concentration showed an antimicrobial response on agar
diffusion (Figure 4a,b). Bacterial suspension cultures in PBS exposed to scaffolds for 24 h demonstrated
the antimicrobial properties of the scaffolds containing silver. The 10 mol.% silver nHA was studied
in a time course assay against bacteria and this showed a significant reduction in bacteria over time
(Figure 4e,f). The scaffold reduced the viable bacteria count to undetectable levels by 48 h for E. coli
and 96 h for S. aureus.
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
Figure 4. Antibacterial studies on E. coli and S. aureus bacteria using the electrospun scaffold. (a) Agar
diffusion test using disks of the electrospun samples against E. coli bacteria. Graph displaying individual
data plots with a line demarking the mean value; (b) Agar diffusion test using disks of the electrospun
samples against S. aureus; (c) Disks of electrospun samples suspended in PBS containing bacteria,
measuring viable colonies after 24 h; (d) Optical images of the area of inhibition ring surrounding a
12-mm disk of scaffold containing either 10 mol.% silver or plain PCL and tested against S. aureus
and E. coli; (e) Bacteria count after E. coli are suspended in PBS and exposed to a disk of electrospun
10 mol.% silver nHA for 3, 18, 24, 48, 72, and 96 h; (f) Same as (e) but using S. aureus bacteria. All graphs
show mean ± standard deviation. All % Ag materials are in mol.%.
3.5. Antimicrobial Impact of Scaffolds
Indirect toxicity assays found that higher silver concentrations were more toxic to both cell types
while a longer, 21-day direct growth experiment showed a reduced toxic impact of these high silver
samples on cells over time. When tested using fibroblast 3T3 cells, all scaffolds had a significantly
higher viability than the negative (cytotoxic) control (Figure 5a). However, the scaffold containing
10 mol.% silver was also significantly different to the cell-only positive control, indicating some toxic
impact. When the materials were tested on primary rat MSCs the toxic impact was more pronounced.
The scaffold with 10 mol.% silver was significantly different to the cell-only positive control, but no
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statistical difference was found with the negative cell death control (Figure 5b). All the remaining
materials were statistically different to the negative cell death controls. A longer, 21-day direct growth
experiment found that cell metabolic activity for 5 mol.% silver-containing scaffolds were significantly
increased compared to the PCL-only scaffolds (Figure 5c). The 10 mol.% silver-containing scaffolds
reduced the metabolic activity when compared to 5 mol.% silver but did not show a toxic impact when
compared to the PCL-only scaffold. Live cell morphology can be observed from live fluorescent images
(Figure 5d) along with the proportion of live to dead cells. Cells appeared to have a more spread out
morphology on the nHA silver-containing material than in the PCL-only control.

Figure 5. Cell toxicity from the electrospun scaffold with different concentrations of silver nHA assessed
by cell metabolic activity via PrestoBlue™ assay. (a) A 48-h noncontact toxicity test with the scaffold
in the media above a monolayer of 3T3 cells. Graph displaying individual data plots with a line
demarking the mean value. Dotted line contains each scaffold under it to be compared to another
condition; (b) A 48-h noncontact toxicity test with the scaffold in the media above a monolayer of
primary rat MSCs. Graph displaying individual data plots with a line demarking the mean value.
Dotted line without star contains each scaffold to be compare to another condition; (c) Cell metabolism
after 21 days of direct culture with the cells seeded on top of the scaffold using metabolic activity at
each time point. Statistics (ANOVA) conducted on the day 21 measurements; (d) Live/dead staining of
MSCs cultured on electrospun scaffolds after 21 days.
3.6. MSC Osteogenic Differentiation Study by ALP Quantification
The impact of silver on the differentiation of primary MSCs down the osteoblast linage
was measured after 21 days in culture by quantifying ALP content per unit of DNA (Figure 6).
ANOVA showed a significant difference with 5 mol.% and the lower silver concentrations in regard to
ALP production. Scaffolds with 10 mol.% silver are not significantly different to 5 mol.% silver scaffolds.
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
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Figure 6. Cell differentiation potential of scaffolds containing different silver contents regarding ALP
presence per unit of DNA after 21 days in culture with primary MSCs. Cells were cultured on top of
the scaffolds. Graph displaying mean value ± standard deviation. N = 2, n = 3.
4. Discussion
Electrospun scaffolds with incorporated silver nano-hydroxyapatite are nontoxic to cells at a
concentration that was antimicrobial, making them suitable for use as antimicrobial bone implants.
In 2017, Anjaneyulu et al. [25] published a study looking into nanoscale electrospun fibers containing
silver-doped hydroxyapatite and its hemocompatibility. Our study took a different direction, producing
scaffoldswith fibers to allow ingrowth of cellswith larger pore sizes having positive impact on osteoblast
cell growth [31]. Our study also included an in-depth microbiology study looking at both contact
and noncontact tests. Investigating the impact of the scaffolds on bone regeneration via analyzing the
toxicity on primary MSCs, for relevant cell toxicity, and 3T3 fibroblasts allowed toxicity comparison
between labs.
The rapid manufacturing of nHA pioneered by Wilcock et al. [10] was replicated to produce
silver-doped nHA powder. The characterization of nanoscale hydroxyapatite indicated it was
comparable to that produced in previous studies. We were able to go one step further by confirming
via TEM XRD that the denser (black) areas on the TEM contained silver. This had been hypothesized
by the previous paper but not directly confirmed [21]. Under XRD we confirmed that the material
was both hydroxyapatite and that it contained silver. TEM analysis showed that the nHA was in a
nanoscale particulate form. The lack of an XRD-measurable silver phosphate phase in the 5 mol.% Ag
nHA demonstrated that the silver had been incorporated into the nHA, either by substitution of silver
into the HA crystal lattice for calcium or by doping of the silver ions onto the HA structure (i.e., not
replacing the ions of the HA crystal). This result was expected for our method as our previous reports
demonstrated a pure hydroxyapatite phase precipitated at 5 mol.% using this reaction [21].
The silver-doped nHA was successfully electrospun into PCL scaffolds. PCL is a popular material
used in bone-related applications as its long-term degradation profile is suited to the slower healing
rate of bone compared to soft tissues. Incorporating silver-containing tricalcium phosphate was
reported by Schneider et al. [26], who found it effective against E. coli but did not test against the
more common bone infection-related pathogen S. aureus. Jiang et al. [19] assessed antibacterial activity
using both of these bacteria with a scaffold formed by in situ foaming, which allowed inclusion of
silver/nHA up to 40% of total weight. This technique does not produce scaffolds, however, instead
producing a monolithic block that would need to be carved to dimensions required during theater.
Anjaneyulu et al. [25] investigated using both bacteria types and manufactured formed scaffolds but
did not assess bone cell biocompatibility.
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Our scaffolds degraded in an accelerated degradation study and showed a two-phase silver
release system. Initially, a rapid burst of silver was released, decreasing in rate until day 7. During the
same initial period of degradation, the polymer had not lost any mass. This rapid silver release is likely
to arise from surface- (or near surface-) bound material. After the initial 7 days, the material lost mass
and silver was released for the remainder of the experiment. Rothstein et al. described this in a model
of an initial surface erosion system, which then transitions into bulk erosion [32]. The combination of
the two allows for a rapid release when first implanted to clear immediate microorganisms and then a
slower sustained release of the remainder of the implant life to prevent colonization from opportunistic
bacteria, which may later attach to the device through a hematogenous route. Liu et al. [15] used
electrochemical deposition of silver onto their electrospun fibers to provide an initial burst of silver over
two days instead of a continual release. This would help prevent potential buildup of silver toxicity but
would not prevent later infections from occurring. A continuous release of calcium and phosphoruswas
detected using ICP, which has been widely reported to stimulate bone regeneration [33]. An implanted
material can act as a desirable location for bacteria to colonize with an infection requiring far fewer
bacteria to start than in a normal tissue [34]. A continuous silver release would prevent opportunistic
bacteria from infecting the implant at a later date. Due to the limited nature of our degradation method
we cannot report on the exact amount of silver released per unit of time in vivo, as physiological
conditions would impose a more complicated environment that may impact silver release. Despite
not knowing the exact amount released, we showed that it is sufficient to prevent bacteria growth in
non-accelerated studies.
Antimicrobial tests using both Gram-positive and Gram-negative bacteria showed that an
antimicrobial response was found for 2, 5, and 10 mol.% incorporated silver-doped nHA. In a contact
agar diffusion assay, both the silver-containing materials were found to produce an area of inhibition,
whereas hydroxyapatite by itself does not [35]. Looking at the reduction of bacteria in solution, both
bacteria were reduced beyond detection within 96 h. In our study we found silver was far more
effective against S. aureus than against the E. coli bacteria. This was unexpected, as the thicker wall
of the Gram-positive S. aureus is arguably better defended against the uptake of silver particles than
thinner Gram-negative cell walls [36]. Resistance to silver can be acquired by bacteria [37], although it
is a relatively broad spectrum medicant. This is significant, as S. aureus is among the most common
pathogens found in bone infections [1,2]. Recent studies have shown that treating the motile S. aureus
in an infected 3D tissue model is more challenging than treating a monolayer bacteria assay [38].
Therefore, this would be the logical progression for the testing of this material. One side effect of silver
is that it can also be toxic to mammalian cells at elevated concentrations, which we investigated with
our scaffolds.
The toxicity of the scaffolds was related to both the silver concentration and on the cell type being
tested. Against the standard cell line of mouse fibroblast 3T3 cells there was a small indication of
toxicity with scaffolds containing 10 mol.% silver. When using a primary rat MSCs there was clear
toxicity detected with this highest concentration of silver. This shows the importance of not just using
a single cell line to determine toxicity of a material but also of the correct choice of relevant cells. For a
more in-depth review of the different modes of action of silver nanoparticles on various cell types,
see Zhang et al. [39]. Using 3T3 cells is a useful method of comparing relative toxicities between
different laboratories as they are well known and utilized in international standards for cytotoxicity
(ISO 10993-5). The primary MSCs are more difficult to standardize between labs and are, therefore,
harder to use to compare toxicity. They do give a more realistic insight on what levels of toxicity
might be harmful in the environment the medical device is intended for. From the results presented,
5 mol.% silver-doped material at 20 wt. mol.% to PCL had an antimicrobial impact without being toxic
to mammalian MSCs.
Using a longer study of 21 days, the 10 mol.% silver nHA scaffolds maintained a viable and
growing cell population on par with the plain PCL material. Hydroxyapatite appeared to boost the
metabolic activity of the MSCs by day 21 with the combination of 5 mol.% silver and hydroxyapatite,
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resulting in even higher levels of cell activity. Increasing the amount of silver to 10 mol.% did not
increase the trend of increased proliferation. The initial high release rate from the material was
potentially too toxic for the cells early on but, once the release level had fallen to a consistent 50 mol.%,
surviving cells would then have been able to proliferate. After this period, the metabolic activity of cell
on the 10 mol.% silver nHA scaffold increased at a similar growth rate to other materials. This is highly
advantageous in a wound-healing application as it would allow an initially high burst to clear bacteria,
which then lowers to allow the mammalian cells to begin the healing process.
Hydroxyapatite is widely reported to increase MSC differentiation into osteoblasts [40–42] so
we focused on investigating the impact of silver on this process showing increased ALP production.
Huge disparity can be found in the literature on whether silver has a significant impact on
differentiation of MSCs. Some authors find that silver nanoparticles have no impact on MSC
differentiation [43,44]. Other papers report on an impact of silver nanoparticles on MSC differentiation
down the osteogenic lineage [45,46]. Conversely, some authors argue that silver particles can cause
adipogenic differentiation [47] of MSCs, whereas others have found no impact at all on adipogenic
differentiation [48]. One aspect that varies between these papers is the size of the silver nanoparticles,
whichmight be a reason between the widely different reporting of the impact of silver on differentiation.
Powers et al. found impact on neurodevelopment from silver on zebrafish PC12 cells, which was very
dependent on both silver composition and silver nanoparticle size [49]. Another variation between
papers is the wide range of different MSCs that are tested for differentiation, from both different tissue
and animal origins. As evenMSCs from different tissue origins vary in behavior, it is not surprising that
different conclusions have been reported by multiple studies [50]. We found that 5 mol.% silver had
the highest ALP production at day 21, although there was no significant difference to 10 mol.% silver.
It is possible that either diminishing returns or an already reached optimum concentration of silver is
the reason for no further increase at 10 mol.% silver. Another explanation is that the slightly more
toxic impact of 10 mol.% silver offsets any additional osteogenic stimulation. Our study demonstrated
that silver-doped nHA incorporated into PCL scaffolds may have a positive effect regarding MSC
differentiation along an osteoblastic lineage due to increased levels of ALP production.
Limitations to the study include no mapping of elements within the electrospun membrane
containing nHA. However, Figure 2b does show evidence that the material is present within the
electrospun membranes but the precise location of the nHA is not known. Another limitation is that,
while using bacteria typical of infections in bone, neither of the isolates was taken from a patient bone
infection. Another limitation on the microbiology side is the simple nature of the tests used; it should be
considered that (along with other disparities) osteomyelitis is associated with a hypoxic environment,
which was not reflected by our experiments. Further work is needed to address these issues, including
the use of a bone infection model to more accurately reproduce the conditions found in vivo. In a
recent study we found that a material with antimicrobial impact on planktonic bacteria and simple
biofilm models was then not effective on P. aeruginosa in tissue-engineered skin models, believed to be
due to the bacteria motility [24]. This is something we intend to investigate in future work.
This research found that silver nHA containing scaffolds has the potential to act as an antimicrobial
scaffold while stimulating bone tissue regeneration. The scaffolds degrade slowly and release a
continuous amount of silver into the local environment over time. They are nontoxic to mammalian
cells at a concentration that is toxic to both Gram-negative and Gram-positive bacterial strains.
Investigating the impact of silver on MSC differentiation has suggested that higher values of silver
promote MSC differentiation.
5. Conclusions
Silver-doped nanoscale hydroxyapatite may be incorporated into electrospun PCL scaffolds to
fabricate a device that is both nontoxic to cultured mammalian cells and capable of inhibiting the
growth of pathogenic microorganisms. The scaffold demonstrated antibacterial activity against both
Gram-positive and Gram-negative bacterial strains commonly found in bone infections. The material
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was shown to release silver in an initial burst followed by a more sustained bulk degradation
release. Silver appeared to enhance MSC differentiation down an osteogenic path when used in
nontoxic concentrations. Silver-doped nHA containing scaffolds exhibited antimicrobial activity while
stimulating bone tissue regeneration, which shows promise as a dual-action medical device to address
unmet clinical needs in orthopedic and dental bone surgery.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4983/11/3/58/s1,
Figure S1: EDX elemental mapping of 10 Ag mol.% samples detecting oxygen, phosphorus, calcium and silver.
TEM image of the analysed material is also shown for comparison along with an overlay image of all elements in a
single frame.
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